Bicyclomycin (BCM) is a clinically promising antibiotic that is biosynthesised by Streptomyces 20 cinnamoneus DSM 41675. BCM is structurally characterized by a core cyclo(L-Ile-L-Leu) 2,5-21 diketopiperazine (DKP) that is extensively oxidized. Here, we identify the BCM biosynthetic gene 22 cluster, which shows that the core of BCM is biosynthesised by a cyclodipeptide synthase and the 23 oxidative modifications are introduced by five 2-oxoglutarate-dependent dioxygenases and one 24 cytochrome P450 monooxygenase. The discovery of the gene cluster enabled the identification 25 of BCM pathways encoded in the genomes of hundreds of Pseudomonas aeruginosa isolates 26 distributed globally, and heterologous expression of the pathway from P. aeruginosa SCV20265 27 demonstrated that the product is chemically identical to BCM produced by S. cinnamoneus. 28 Overall, putative BCM gene clusters have been found in at least seven genera spanning 29 Actinobacteria and Proteobacteria (Alpha-, Beta-and Gamma-). This represents a rare example 30 of horizontal gene transfer of an intact biosynthetic gene cluster across such distantly related 31 bacteria, and we show that these gene clusters are almost always associated with mobile genetic 32 elements.
INTRODUCTION 45
Bicyclomycin (BCM) is a broad-spectrum antibiotic active against Gram-negative bacteria that 46 was first isolated in 1972 from Streptomyces cinnamoneus (originally named Streptomyces sapporoensis) (1) and is also produced by two other Streptomyces species (2, 3). BCM (also known encoded in this cluster, but is at the end of the bcmA-G operon instead of preceding bcmA (Fig. 146 1B). 147 No BCM production was detected in cultures of P. aeruginosa SCV20265, so heterologous 148 expression of the gene cluster was carried out to determine whether the pathway is functional. 149 The putative bcm cluster (including bcmT) was PCR amplified from SCV20265 gDNA and cloned 150 into pJH10TS (39, 40), which places the putative bcm operon under the control of the synthetic 151 promoter Ptac. Pseudomonas fluorescens SBW25 was transformed with the resulting plasmid 152 (pJH-BCMclp-PA). Several clones of this heterologous expression strain were cultured in a range 153 of production media, and assessed for their ability to produce BCM. LC-MS 2 analysis revealed 154 that P. fluorescens SBW25-pJH-BCMclp-PA efficiently produces BCM after 14 h of growth ( Fig. 3) . 155 The putative BCM detected in these samples exhibited the same retention time, mass and 156 fragmentation profile as a pure BCM standard, including MS signals of m/z 285.11, as observed 157 previously, and m/z 325.10, corresponding to [BCM+Na] + (Fig. 3 and Figs. S3, S4 ). This result is 158 consistent with parallel work from Patteson et al. (32) , but this does not preclude the possibility 159 of variation in stereochemistry at one more positions in the molecule. We therefore scaled up 160 production, purified the compound and subjected it to NMR analysis ( 1 H, 13 C, COSY, HMBC, 161 HSQC), which provided identical spectra (Figs. S5 to S10, Table S2 ) to authentic BCM reported 162 previously (41). Pseudomonas-produced BCM also had the same optical rotation as a BCM 163 standard, confirming that they are stereochemically identical. 164 One of the most efficient media for BCM production in P. fluorescens was SCFM, a synthetic 165 medium that mimics the salt and amino acid composition from cystic fibrosis sputum samples 166 (42). The composition of this medium was simplified to generate bicyclomycin production 167 medium (BCMM), in which cultures of P. fluorescens SBW25-pJH-BCMclp-PA provided BCM yields 168 of 34.5 ± 2.1 mg/L in only 14 h. Interestingly, we could detect at least six additional compounds 169 in the heterologous expression strain in comparison to a negative control strain harbouring 170 empty pJH10TS ( Fig. 3 and Figs. S3, S4 ). All of these compounds have masses compatible with 171 BCM-like compounds (Table S3 ) and some have BCM-like MS 2 fragmentation patterns, such as a 172 loss of 74.04 Da that corresponds to fragmentation of the oxidized leucine side chain (Fig. S4) . 173 This production profile makes P. fluorescens a promising BCM production system when compared 174 to the complex media and longer incubation times required to produce BCM in Streptomyces 175 species. In contrast, we could not detect any BCM-like molecules in cultures of wild type P. 176 aeruginosa SCV20265, suggesting that additional factors are required to activate the expression 177 of an otherwise functional gene cluster. 178 Organisation, taxonomic distribution and phylogeny of the bcm cluster 179 The presence of seven contiguous biosynthetic genes that make the same antibiotic in both 180 Gram-positive and Gram-negative bacteria was a fascinating result. The production of the same 181 compound in such distantly related organisms (bacteria that are evolutionarily at least 1 billion 182 years apart (43)) is incredibly rare, but not unprecedented (44) . To investigate this unusual result, 183 a BLASTP search using BcmA was used to identify every putative bcm gene cluster (bcmA-G) in 184 sequenced bacterial genomes. In total, 724 candidates were identified, where 31 are found in a 185 variety of taxa and the remaining sequences all come from Pseudomonas species, in particular P. 186 aeruginosa. This initial dataset was filtered (see Material and Methods) to generate a final Streptomyces species besides S. cinnamoneus, as well as 20 Mycobacterium chelonae strains, 190 Williamsia herbipolensis (order Corynebacteriales), Actinokineospora spheciospongiae (order 191 Pseudonocardiales) and the Gram-negative bacteria Burkholderia plantarii and Tistrella mobilis 192 (Beta-and Alphaproteobacteria, respectively). Furthermore, a fragmented bcm-like gene cluster 193 was identified in Photorhabdus temperata (Gammaproteobacteria) by BLAST analysis of BcmA 194 and the P450 BcmD. This cluster is split across two different contigs (accession numbers 195 NZ_AYSJ01000007 and NZ_AYSJ01000009), where it is accompanied by transposase genes, and 196 was therefore not included in our dataset. 197 Most bcm gene clusters from Gram-positive bacteria share the same gene organisation, with 198 bcmT in a divergent operon upstream of bcmA, whereas in all the Gram-negative bacteria (and 199 Actinokineospora) bcmT is downstream of bcmG. Streptomyces ossamyceticus is the only 200 representative that lacks a transporter gene immediately adjacent to the biosynthetic genes. 201 Additionally, the MFS transporters from Gram-positive gene clusters only share 27-30% sequence 202 identity (approx. 40% coverage) with MFS transporters from Gram-negative gene clusters, 203 suggesting that the transporters have been recruited independently in these distant bacteria. 204 All the bcm gene clusters identified in this work were analysed phylogenetically by constructing 205 a maximum likelihood tree from the nucleotide sequence spanning bcmA-G. This showed that 206 their evolutionary relationship correlates tightly with the taxonomy of the strains (Fig. 4A ). chelonae gene clusters (these two genera belong to the order Corynebacteriales) (Fig. 4B ). All P. 213 aeruginosa gene clusters are ~99% identical to each other ( Fig. 4A and Fig. S11 ), whereas the two 214 most distantly related streptomycete gene clusters share 69% identity and 83% coverage.
215
Mobile genetic elements associated with bcm-like gene clusters 216 The conserved organisation of biosynthetic genes, along with the phylogenetic relationship 217 between the S. cinnamoneus and P. aeruginosa CDPSs (32), strongly implies that the bcm gene 218 cluster has been horizontally transferred between numerous bacteria. The increased sequence 219 divergence of the bcm gene clusters in Streptomyces species suggests that the gene cluster may 220 have originated from this taxonomic group, although it is difficult to prove this hypothesis, as the 221 gene clusters in all strains appear to have adapted to their hosts, making HGT difficult to infer. 222 Despite the below average GC content of the clusters (59.6% in P. aeruginosa SCV20265 and 223 70.8% in S. cinnamoneus) versus the genome averages (66.3% and 72.4%, respectively), the 224 clusters were not predicted to be part of genomic islands in these strains when analysed with 225 IslandViewer4 (45). 226 However, analysis of the genomic context of bcm gene clusters in P. aeruginosa strains strongly 227 supports an insertion hypothesis, since the genes that flank the cluster are contiguous in a 228 number of P. aeruginosa strains that lack the cluster (Fig. S12 ). Most notably, bcmT is adjacent 229 to the glucosamine-fructose-6-phosphate aminotransferase gene glmS, and the intergenic region 230 that precedes glmS contains the specific attachment site for transposon Tn7 (attTn7) (46). BL08) have mobile genetic elements integrated next to glmS (Fig. S12 ). Intriguingly, many strains, 233 including the reference strain PAO1, contain a MFS transporter gene (PA5548 in PAO1) adjacent 234 to glmS that is 99% identical with bcmT from SCV20265. This either indicates that the bcm gene 235 cluster recently integrated next to an existing P. aeruginosa transporter, or that a subset of 236 strains lost the biosynthetic genes but retained a potential BCM resistance gene. 237 The bcm-like gene clusters in other Gram-negative bacteria (Burkholderia and Tistrella) and most 238 Gram-positive bacteria are located next to genes coding for integrases, transposases and other 239 genetic mobility elements, which strongly supports HGT of the cluster into these taxa (Figs. 4B 240 and 4C). For example, the mycobacterial clusters are found close to tRNA genes, and their 241 flanking genes are syntenic in some M. abscessus strains, whereas in other M. abscessus strains 242 these genes are separated by a cluster of phage-related genes ( Fig. 4B and Fig. S13 ). In the 243 streptomycetes, the clusters are integrated in different genomic locations, where they are also 244 often associated with mobile genetic elements ( Fig. 4B ). Across all genera, this indicates that bcm 245 gene clusters are almost always located at regions of genomic plasticity.
246
Diversity and geographical distribution of the bcm cluster in P. aeruginosa 247 The high sequence identity of the bcm gene cluster across hundreds of P. aeruginosa strains ( Colombia, Croatia and Israel, among others. This geographic diversity was further augmented by 262 an analysis of all P. aeruginosa strains encoding the pathway (Data set S1). We can therefore 263 conclude that the bcm gene cluster is distributed globally, but within a phylogenetically distinct 264 subset of P. aeruginosa strains. Given this phylogenetic distribution, it is surprising to note that a 265 bcmT gene is also found next to glmS in P. aeruginosa PA14 ( Fig. S12 ). 267 An unusual feature of the bcm gene clusters is the presence of five 2OG-dependent dioxygenase 268 genes. While it is possible that they originally arose by gene duplication events, the S. 269 cinnamoneus 2OG-dependent dioxygenases only possess 33-45% sequence identity with each 270 other ( Figure S14 ). We hypothesised that an analysis of the diversity of the bcm 2OG-dependent 271 dioxygenases across multiple taxa could provide an insight into gene cluster evolution. We 272 therefore constructed a maximum likelihood tree using protein sequences of every 2OG-273 dependent dioxygenase (BcmB, C, E, F and G homologs) from both S. cinnamoneus and P. aeruginosa SCV20265, as well as from other selected P. aeruginosa strains and at least one 275 representative from the other genera that encode bcm-like gene clusters. 276 In contrast to the overall gene cluster phylogeny, the bcm oxidases group primarily based on their 
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2OG-dependent dioxygenase phylogeny
290
In summary, we demonstrate that the antibiotic BCM is a CDPS-derived natural product whose 291 biosynthetic gene cluster is present in a diverse array of both Gram-positive and Gram-negative 292 bacteria. This characterisation was supported by heterologous expression of pathways from S. 293 cinnamoneus and P. aeruginosa, where the pathway product was proven to be stereochemically 294 identical to authentic BCM. We have also showed that the previously orphan P. aeruginosa 295 pathway is a promising system for the production of BCM and related derivatives. The bcm cluster is dispersed across a number of taxonomically distant bacteria, including Alpha-, Beta- 297 and Gammaproteobacteria, as well as several Actinobacteria families. The widespread presence 298 of bcmT genes in P. aeruginosa (even those that lack the biosynthetic genes ( Fig. S12) ), may 299 explain why BCM is inactive towards P. aeruginosa (49), but further work is required to determine 300 whether bcmT confers BCM resistance. 301 The presence of mobile genetic elements associated with the bcm gene cluster in many bacteria Listeria monocytogenes that modifies intestinal microbiota to promote infection (55). In addition, given the frequent horizontal transfer of the bcm gene cluster and its extensive association with 319 mobile genetic elements, it is interesting to note that transcription terminator Rho most strongly 320 represses transcription of horizontally acquired regions of genomes (56), an activity that would 321 be specifically inhibited by BCM (7). It is known that phages recruit genes from bacteria that 322 increase their fitness and that of their hosts (57, 58) and this may occur with the bcm gene cluster. 323 These intriguing observations invite further work to determine the natural role of BCM. E. coli and Pseudomonas strains were grown in lysogeny broth (LB) at 37 °C (except for P. 340 fluorescens SBW25, which is temperature sensitive and was grown at 28 °C) and stored at -70°C 341 in 50% glycerol stocks. Streptomyces strains were cultured in liquid tryptone soya broth (TSB, 342 Oxoid) or solid soya flour mannitol (SFM) medium (59) at 28-30 °C and stored at -70 °C as 20% 343 glycerol spore stocks. 344 The following media were used for bicyclomycin production experiments: Aizunensis production 345 medium (AIZ), adapted from (60) 362 Genomic DNA of S. cinnamoneus DSM 41675 was isolated following the salting out protocol (59) , 363 which was then subjected to a TruSeq PCR-free library preparation and then sequenced using 364 Illumina MiSeq (600-cycle, 2x300 bp) at the DNA Sequencing Facility, Department of 365 Biochemistry, University of Cambridge (UK). MinION nanopore sequencing (Oxford Nanopore 366 Technologies, UK) was carried out using the following protocol. 367 A single colony from S. cinnamoneus grown on solid CIN medium was used to inoculate 50 mL 368 TSB, which was incubated at 28 °C overnight with shaking at 250 rpm. 1 mL of this seed culture 369 was used to inoculate a further 50 mL TSB, which was again incubated at 28 °C overnight with 370 shaking at 250 rpm. DNA was extracted from 10 mL of this culture using the salting out procedure 371 as described before (59) and resuspended in 5 mL Tris-EDTA (TE) buffer. DNA concentration was 372 quantified using a Qubit 2.0 Fluorometer (Life Technologies) and fragment length and DNA 373 quality was assessed using the Agilent TapeStation 2200 (Agilent Technologies). 374 Genomic DNA (~11 µg in 100 µL) was fragmented using a Covaris g-TUBE (Covaris, UK) centrifuged 375 at 3380 x g for 90 s x 2 to achieve a fragment distribution with a peak at ~16 kb. The sequencing 376 library was prepared using Oxford Nanopore Technologies Nanopore Sequencing Kit SQK-NSK007 Table S1 . The hybrid assembly genome sequence was annotated using 394 Prokka (65), which implements Prodigal (66) as an orf calling tool.
Genome sequencing, annotation and bioinformatics analysis of S. cinnamoneus
395
Cloning the S. cinnamoneus bcm gene cluster 396 The DNA region containing the bcm gene cluster was PCR amplified from S. cinnamoneus gDNA 397 using primers pIJ-bcm_start and pIJ-bcm_end with Herculase II Fusion DNA polymerase (Agilent). 398 The resulting 6981 bp fragment was gel purified and inserted via Gibson assembly (29) into 399 pIJ10257 (a ΦBT1 integrative and hygromycin resistant vector (28)) linearized with NdeI and PacI 400 to generate plasmid pIJ-BCM. To verify that the cluster sequence in this construct was correct, 401 the plasmid was Sanger sequenced using primers BCM_seq_1 to BCM_seq_8. All other DNA 402 isolation and manipulation techniques were performed according to standard procedures (67). 404 Methylation-deficient E. coli ET12567 carrying the helper plasmid pUZ8002 (68) was transformed 405 with pIJ-BCM by electroporation. This was employed as the donor strain in an intergeneric 406 conjugation with S. coelicolor M1146 and M1152 (31) , which was performed following standard 407 protocols (59) . Exconjugants were screened by colony PCR with primers bcm-cdps_chk_fw and 408 bcm-cdps_chk_rv to confirm plasmid integration. Control strains containing empty pIJ10257 409 were also generated using the same methodology. in 50 mL flasks, which were incubated at 28 °C with shaking at 250 rpm for 3 days. 500 μL of this 434 seed culture were used to inoculate 7 mL CIN medium in 50 mL Falcon tubes covered with foam 435 bungs. These production cultures were incubated at 28 °C with shaking at 250 rpm for 4 days. 436 The same procedure was used for S. coelicolor M1146-pIJ-BCM and M1152-pIJ-BCM. For 437 production in P. fluorescens, 20 μL of cell stocks were used to inoculate 10 mL SCFM in 30 mL 438 universal polystyrene tubes. These cultures were grown overnight at 28 °C with shaking at 250 439 rpm, with the screw caps slightly loose to allow aeration, and 400 μL aliquots were used to 440 inoculate 10 mL BCMM in 50 mL Falcon tubes covered with foam bungs. Production cultures were 441 incubated for 12-16 h at 28 °C with shaking at 250 rpm. 442 For the analysis of BCM production, 1 mL production culture samples were centrifuged at 18,000 443 x g for 5 minutes. 5 μL of these samples were analysed by LC-MS using a Luna Omega 1.6 μm 
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